Cohen v. Implant Innovations, Inc.

259 F.R.D. 617, 2008 U.S. Dist. LEXIS 64144, 2008 WL 3927223
CourtDistrict Court, S.D. Florida
DecidedAugust 21, 2008
DocketNo. 07-20777-CIV
StatusPublished
Cited by18 cases

This text of 259 F.R.D. 617 (Cohen v. Implant Innovations, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cohen v. Implant Innovations, Inc., 259 F.R.D. 617, 2008 U.S. Dist. LEXIS 64144, 2008 WL 3927223 (S.D. Fla. 2008).

Opinion

ORDER ADOPTING REPORT AND RECOMMENDATION (D.E.112); DENYING PLAINTIFF’S MOTION FOR CLASS CERTIFICATION (D.E.60); AND DENYING AS MOOT DEFENDANT’S MOTION FOR JUDGMENT ON THE PLEADINGS ON COUNT III OF PLAINTIFF’S COMPLAINT (D.E.54)

JOAN A. LENARD, District Judge.

THIS CAUSE is before the Court on the Report and Recommendation issued by U.S. Magistrate Judge John J. O’Sullivan on June 13, 2008 (“Report,” D.E. 112), recommending that the Motion for Class Certification filed by Plaintiff on December 7, 2008 (“Motion,” [620]*620D.E. 60) be denied in its entirety. On June 30, 2008, Plaintiff filed its Objections to the Report (“Objections,” D.E. 116). On July 18, 2008, Defendant filed its response to Plaintiffs Objections (“Response to Plaintiffs Objections,” D.E. 118). Having reviewed the Motion, the related pleadings, and the record de novo, the Court finds as follows:

I. Procedural Background and Report

As the Magistrate Judge noted in the Report, Plaintiff William M. Cohen, D.M.D., M.S., Greater St. Louis Periodontics, P.C. (“Plaintiff’)1 filed a complaint against Defendant Implant Innovations, Inc. d/b/a “3i” (“Defendant”) alleging claims for breach of express and implied warranties (Counts I and II) and a claim under Florida’s Deceptive and Unfair Trade Practices Act (“FDUTPA”) (Count III) arising from the sale of permanent endosseous dental implants, known as the Osseotite NT Certain Implant, and related system components (the “Implant Product”), that were allegedly designed, manufactured, marketed, distributed, and sold by Defendant. (See D.E. 112 at 1; see also D.E. 93 ¶ 7.) Plaintiff then filed the instant Motion on December 7, 2007, initially seeking to certify as a class on its three claims “all periodontists, oral surgeons, and similar medical dental professionals” in the United States who purchased the Implant Product from Defendant and have had to replace, at them cost, the Implant Product at a rate substantially higher than warranted, during the period July 28, 2003 — when the Implant Product was first marketed and sold to periodontists throughout the United States — to the date of the trial. (D.E. 60; see also D.E. 61-62; D.E. 93 ¶¶ 10-11.) Defendant filed its opposition on January 14, 2008 (D.E.77), and on February 5, 2008, Plaintiff filed its reply (D.E.88). In its reply, Plaintiff sought to amend the class definition on its breach of express warranty claims only, limiting the class to members from certain states (and the District of Columbia) which do not require reliance as an element of a breach of express warranty claim and who “received marketing materials about Implant Product’s success rate, and have had to replace the Implant Product at a rate higher than warrantied within the applicable statute of limitations.” (See id. at 8-9; see also D.E. 112 at 5.)

In addition, the Magistrate Judge permitted Plaintiff to file a supplemental memorandum of law (D.E.99), and permitted Defendant to file a response to that supplemental memorandum of law (D.E.102). On April 18, 2008, the Magistrate Judge heard oral argument on this Motion. (D.E. 112 at 2.) At oral argument, Plaintiff proposed further modifications to the proposed class on its breach of express warranty claims, namely, all periodontists, oral surgeons, and similar medical-dental professional who had experienced a failure rate in excess of their normal rate and whose failure rate was higher than warranted by Defendants. (See id. at 5.)

As a threshold matter, the Magistrate Judge determined that Plaintiff has failed to set forth adequately defined and clearly ascertainable classes, because determining who qualified as members of each of the proposed classes would require the Court to first make a legal determination on Defendant’s warranted rate of failure, which would in turn require the Court to decide whether the marketing materials prepared by Defendant constitute an express warranty under applicable law, and then determine that each putative class member experienced a failure rate that was higher than warranted by Defendant. (D.E. 112 at 6.) The Magistrate Judge then noted that, under Plaintiffs definitions, an individual who purchased a single Implant Product and unsuccessfully implanted it in a patient would be included in the class, regardless of the reason for the failure, because he or she experienced a 100% failure rate, and would have had to replace the product at a higher rate than warranted. (Id.) The Magistrate Judge then addressed the modifications proposed by Plaintiff at oral argument involving defining the class based on a “normal failure rate,” and found that the Court would still be required to make factual determinations as to each individual putative class member’s “normal fail[621]*621ure rate,” and that, in addition, Plaintiff fails to explain how, and on what period of time, each member’s “normal failure rate” would be determined. (Id. at 6-7.) The Magistrate Judge also noted that medical records may no longer be available, further complicating the task of defining the classes as modified by Plaintiff. (Id. at 6.) Recognizing nonetheless that a deficient class definition can be modified, the Magistrate Judge then analyzed the requirements under Federal Rule of Civil Procedure 23 (“Rule 23”) for class certification.

As to numerosity, the Magistrate Judge found that, assuming Plaintiff could present adequate proposed class definitions, Plaintiff satisfies the numerosity requirement in light of the large number of Implant Products sold by Defendant and the geographic dispersion of the proposed class members. (Id. at 8.) As to commonality, the Magistrate Judge found that the questions linking the putative class members are substantially related to the resolution of the litigation, and, given the low threshold for establishing commonality, Plaintiff has satisfied the commonality requirement. (Id. at 9-10.)

As to typicality, the Magistrate Judge found that Plaintiff has satisfied the typicality requirement for both breach of express and implied warranty claims, noting that Defendant does not challenge typicality regarding Plaintiffs breach of express warranty claim, and that the Supplemental Affidavit of William M. Cohen supports a finding of privity between Plaintiff and Defendant sufficient to demonstrate that the Plaintiffs claims are typical of the class. (Id. at 10-11.) With respect to the FDUTPA claim, the Magistrate Judge first engaged in an extensive eonflict-of-laws analysis, and found that Missouri — not Florida' — has the most significant relationship to the Plaintiffs unfair trade practice claim, and, as such, Plaintiff does not have standing to assert a FDUTPA claim on behalf of each putative class member; thus, the Magistrate Judge found that Plaintiff has not satisfied the typicality requirement with respect to its FDUTPA claim. (Id. at 12-26.)

As to adequacy, the Magistrate Judge found that Plaintiff does not have any apparent conflicting interests with potential class members; that Plaintiff appears to be involved in the litigation; that Defendant does not question the qualifications, experience or ability of Plaintiffs counsel; and that Plaintiffs counsel appears to be well-equipped to prosecute this action. (Id. at 26.) Thus, with respect to the warranty claims, the Magistrate Judge found that Plaintiff satisfies the adequacy requirement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Blitz v. Monsanto Co.
317 F. Supp. 3d 1042 (W.D. Wisconsin, 2018)
Hummel v. Tamko Bldg. Prods., Inc.
303 F. Supp. 3d 1288 (M.D. Florida, 2017)
Carroll v. Phillip Morris USA, Inc.
Superior Court of Delaware, 2017
Carroll v. Philip Morris USA, Inc.
163 A.3d 91 (Superior Court of Delaware, 2017)
Melton v. Century Arms, Inc.
243 F. Supp. 3d 1290 (S.D. Florida, 2017)
Schechner v. Whirlpool Corp.
237 F. Supp. 3d 601 (E.D. Michigan, 2017)
Robert Brown v. Electrolux Home Products, Inc.
817 F.3d 1225 (Eleventh Circuit, 2016)
In re: Dial Complete Marketing
2015 DNH 222 (D. New Hampshire, 2015)
In re Shop-Vac Marketing & Sales Practices Litigation
964 F. Supp. 2d 355 (M.D. Pennsylvania, 2013)
Tempay, Inc. v. Biltres Staffing of Tampa Bay, LLC
945 F. Supp. 2d 1331 (M.D. Florida, 2013)
Keegan v. American Honda Motor Co.
838 F. Supp. 2d 929 (C.D. California, 2012)
City of St. Petersburg v. Total Containment, Inc.
265 F.R.D. 630 (S.D. Florida, 2010)
Siever v. BWGaskets, Inc.
669 F. Supp. 2d 1286 (M.D. Florida, 2009)
David v. American Suzuki Motor Corp.
629 F. Supp. 2d 1309 (S.D. Florida, 2009)
Brisson v. Ford Motor Co.
602 F. Supp. 2d 1227 (M.D. Florida, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
259 F.R.D. 617, 2008 U.S. Dist. LEXIS 64144, 2008 WL 3927223, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cohen-v-implant-innovations-inc-flsd-2008.